<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00199628</url>
  </required_header>
  <id_info>
    <org_study_id>I05001</org_study_id>
    <nct_id>NCT00199628</nct_id>
  </id_info>
  <brief_title>Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization</brief_title>
  <official_title>Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Limoges</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Limoges</source>
  <brief_summary>
    <textblock>
      Problems of compatibility between a mother and her child are frequent. The most well-known
      case can be illustrated by the fetomaternal blood group incompatibility (rhesus factor) which
      can induce severe anemia of the fetus.

      The investigators recently proved that incompatibility between mother and child can concern
      an organ leading to a tissular alloimmunization. For example, neonatal membranous
      glomerulonephritis (a kidney disease) can result from this mechanism.

      The purpose of this network is to detect and study neonatal diseases induced by tissular
      fetomaternal alloimmunization. The detection of these diseases will be performed by the
      mother's serum analysis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2005</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">100</enrollment>
  <condition>Glomerulonephritis, Membranous</condition>
  <condition>Neonatal Diseases and Abnormalities</condition>
  <condition>Hemochromatosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        pregnant woman
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Mothers having a child suffering from:

          -  Neonatal membranous glomerulonephritis

          -  Unexplained neonatal tubular defect

          -  Unexplained thrombotic microangiopathy

          -  Neonatal hemochromatosis

        Exclusion Criteria:

          -  Any cause explaining the child's disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnant woman</gender_description>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent Guigonis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pediatrics, Limoges University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Limoges University Hospital</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <study_first_submitted>September 14, 2005</study_first_submitted>
  <study_first_submitted_qc>September 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2005</study_first_posted>
  <last_update_submitted>January 11, 2019</last_update_submitted>
  <last_update_submitted_qc>January 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fetomaternal tissular alloimmunization</keyword>
  <keyword>Mothers having a child suffering from:</keyword>
  <keyword>neonatal membranous glomerulonephritis</keyword>
  <keyword>unexplained neonatal tubular defect</keyword>
  <keyword>unexplained thrombotic microangiopathy</keyword>
  <keyword>neonatal hemochromatosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glomerulonephritis</mesh_term>
    <mesh_term>Glomerulonephritis, Membranous</mesh_term>
    <mesh_term>Hemochromatosis</mesh_term>
    <mesh_term>Infant, Newborn, Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

